[
  {
    "ts": "2025-12-19T09:30:00+00:00",
    "headline": "Down 80%, Should You Buy the Dip on Moderna?",
    "summary": "Your decision on whether to invest now depends to some extent on your investment strategy.",
    "url": "https://www.fool.com/investing/2025/12/19/down-80-should-you-buy-the-dip-on-moderna/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "e406e15c-f46a-3c6f-891f-153addcaf7e4",
      "content": {
        "id": "e406e15c-f46a-3c6f-891f-153addcaf7e4",
        "contentType": "STORY",
        "title": "Down 80%, Should You Buy the Dip on Moderna?",
        "description": "",
        "summary": "Your decision on whether to invest now depends to some extent on your investment strategy.",
        "pubDate": "2025-12-19T09:30:00Z",
        "displayTime": "2025-12-19T09:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/1cadddbdf61f5428bcd51ff178dd39e9",
          "originalWidth": 1200,
          "originalHeight": 800,
          "caption": "An investor looks pensively at a laptop screen at home.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/durqZJ1rlVd.d6npOlKK2w--~B/aD04MDA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/1cadddbdf61f5428bcd51ff178dd39e9.cf.webp",
              "width": 1200,
              "height": 800,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dTcmh8yHlpiAfzh.UYZmKQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/1cadddbdf61f5428bcd51ff178dd39e9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2025/12/19/down-80-should-you-buy-the-dip-on-moderna/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/down-80-buy-dip-moderna-093000960.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-12-19T15:10:00+00:00",
    "headline": "MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab",
    "summary": "Moderna secures up to $54.3 million from CEPI to fund a pivotal phase III study of its mRNA-based H5 pandemic flu vaccine candidate, mRNA-1018.",
    "url": "https://finance.yahoo.com/news/mrna-cepi-funding-phase-iii-151000871.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "8fd383cb-7744-3e6e-b56b-76b0fbd12ac8",
      "content": {
        "id": "8fd383cb-7744-3e6e-b56b-76b0fbd12ac8",
        "contentType": "STORY",
        "title": "MRNA to Get CEPI Funding for Phase III Study on Pandemic Influenza Jab",
        "description": "",
        "summary": "Moderna secures up to $54.3 million from CEPI to fund a pivotal phase III study of its mRNA-based H5 pandemic flu vaccine candidate, mRNA-1018.",
        "pubDate": "2025-12-19T15:10:00Z",
        "displayTime": "2025-12-19T15:10:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RbEQ9ffI_C.cs8maxLm5aA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/7WrOhRUUvHYeo9ae0mpZAg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9e8d93e17a792e7de990e3344e61fa6a.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/mrna-cepi-funding-phase-iii-151000871.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/mrna-cepi-funding-phase-iii-151000871.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRNA"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]